Last Updated: 14th November 2022

Johnson & Johnson is a 140,000 employee broadbased healthcare company providing products from baby-oil and Band-Aids, to medical devices and pharmaceuticals

Employees: 140,000

Revenue: $95bn for FY2021

HQ Location: New Brunswick, New Jersey, US

What they do:

  • Largest and broad product range healthcare company

  • Three business units: Pharmaceutical, MedTech and Consumer Health

  • 29 platforms/products with over $1bn in annual sales

Their vision and priorities:

  • Enterprise: focus on achieving near-term financial targets, maintaining high quality standards, and continuing to invest for long-term value creation.

  • Pharmaceutical: Expect to deliver above-market growth in near and long term through portfolio maximisation and R&D investment

  • MedTech: Continue to focus on improved execution through market share momentum and enhanced cadence of innovation

  • Consumer Health: Deliver science-backed innovation and digital, consumer-centric solutions while advancing towards the creation of a successful new standalone industry leader

Three things to know right now

Joaqin Duato is the new CEO

Joaqin became CEO in January 2022 following 33 years at the company.

“Today, when it comes to the vision for Johnson & Johnson, I’m once again looking 25 years out, steering toward a horizon where we have achieved transformational medical innovations.”

Spin Off of Consumer Products

The investor proposition specifically describes preparing the consumer health division (currently the smallest by revenue size) to be an independent business.

Sellers should consider this when thinking about how the company might purchase solutions in the near to medium future.

Pharmaceutical is largest business segment

Sales across the business continue to grow:

Pharmaceutical: $52.1 bn

Consumer Health: $14.6bn

MedTech: $27.1bn

What does each business unit do?

Consumer Health Products

This business unit manufactures products to us as consumers including:

  • Self Care - medicines for allergies, pain relief, and colds

  • Skin Health and Beauty - cleansers, sun protection and moisturisers

  • Essential Health - Band Aid, mouth washes and sanitary products

Med Tech

This business unit produces medical devices and products for the healthcare profession including:

Orthopaedics - products for surgery including operating room products and accessories

Surgery - developing products that allow surgeons to operate safely

Interventional Solutions - products that help patients with heart rhythm disorders and neurovascular care

Vision - products focused on eyesight

Pharmaceutical Products

This business unit researches and develop medical drugs and treatments including

  • Vaccines

  • Heart care

  • Infectious diseases

  • Neuroscience

  • Oncology (cancer treatments)

Their financial calendar

Q1: January-March - Earnings 18th April

Q2: April-June - Earnings 18th July

Q3: July-September - Earnings 18th October

Q4: September-December - Earnings 18th January

Positives from the last earnings report:

  • 3rd Quarter Sales increased 1.9% to $23.8bn

Challenges from the last earnings report:

  • Consumer Health reported decreased sales of 0.4%

Next Earnings Report:

Around 24th January 2023

Something to add?

If you have new information that would help others, drop us a note through this form and we’ll verify prior to updating this page.

Thanks for helping,